Tissue Regenix Group plc's (LON:TRX) Share Price Is Matching Sentiment Around Its Revenues
Jun 01
U.K. (FTSE) Biotech Industry Analysis
UpdatedJun 05, 2024
DataAggregated Company Financials
Companies25
- 7D1.4%
- 3M7.4%
- 1Y-21.2%
- YTD-8.6%
In the last week, the Biotech industry is up 1.4%, with Genus up 4.4%. In the same time, Faron Pharmaceuticals Oy was down 41%. However, the industry is down 21% over the past year. Earnings are forecast to grow by 28% annually.
Industry Valuation and Performance
Has the U.K. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 06 Jun 2024 | UK£3.0b | UK£837.0m | -UK£285,185,496.43 | 30.9x | -10.5x | 3.6x |
| Sat, 04 May 2024 | UK£3.0b | UK£836.7m | -UK£304,434,404.76 | 31.4x | -9.8x | 3.6x |
| Mon, 01 Apr 2024 | UK£3.1b | UK£903.1m | -UK£202,203,282.48 | 28.6x | -15.2x | 3.4x |
| Wed, 28 Feb 2024 | UK£3.2b | UK£896.6m | -UK£197,653,789.45 | 32.8x | -16.3x | 3.6x |
| Fri, 26 Jan 2024 | UK£6.5b | UK£1.3b | -UK£245,281,122.00 | 39.1x | -26.3x | 5.1x |
| Sun, 24 Dec 2023 | UK£6.3b | UK£1.3b | -UK£245,293,031.00 | 38x | -25.7x | 5x |
| Tue, 21 Nov 2023 | UK£6.4b | UK£1.3b | -UK£246,319,118.00 | 38.7x | -26x | 5x |
| Thu, 19 Oct 2023 | UK£6.5b | UK£1.3b | -UK£251,266,337.00 | 39.2x | -26x | 5.1x |
| Sat, 16 Sep 2023 | UK£6.6b | UK£1.3b | -UK£207,212,895.00 | 23.1x | -31.7x | 5.1x |
| Mon, 14 Aug 2023 | UK£6.7b | UK£1.3b | -UK£208,032,536.00 | 23.6x | -32.4x | 5.4x |
| Wed, 12 Jul 2023 | UK£6.8b | UK£1.3b | -UK£208,242,830.00 | 23.9x | -32.5x | 5.4x |
| Fri, 09 Jun 2023 | UK£7.0b | UK£1.3b | -UK£206,138,475.00 | 23x | -33.9x | 5.6x |
| Sun, 07 May 2023 | UK£7.1b | UK£1.3b | -UK£204,849,398.00 | 23.6x | -34.8x | 5.7x |
| Tue, 04 Apr 2023 | UK£7.2b | UK£1.2b | -UK£154,109,502.00 | 24.2x | -46.6x | 5.8x |
| Thu, 02 Mar 2023 | UK£7.5b | UK£1.2b | -UK£156,752,890.00 | 26.5x | -47.8x | 6.1x |
| Sat, 28 Jan 2023 | UK£7.4b | UK£1.2b | -UK£146,330,987.00 | 26.8x | -50.8x | 6.4x |
| Mon, 26 Dec 2022 | UK£7.5b | UK£1.2b | -UK£138,559,947.00 | 26.9x | -53.9x | 6.4x |
| Wed, 23 Nov 2022 | UK£7.6b | UK£1.2b | -UK£140,234,698.00 | 24.8x | -54.4x | 6.6x |
| Fri, 21 Oct 2022 | UK£6.9b | UK£1.2b | -UK£150,459,849.00 | 26.2x | -46x | 6x |
| Sun, 18 Sep 2022 | UK£7.7b | UK£1.2b | -UK£179,626,949.00 | 26x | -43.1x | 6.7x |
| Tue, 16 Aug 2022 | UK£7.6b | UK£1.1b | -UK£201,188,859.00 | 38.1x | -37.7x | 6.8x |
| Thu, 14 Jul 2022 | UK£6.8b | UK£1.1b | -UK£202,485,801.00 | 34.2x | -33.8x | 6.1x |
| Sat, 11 Jun 2022 | UK£6.9b | UK£1.1b | -UK£158,354,011.00 | 36.4x | -43.8x | 6.2x |
| Mon, 09 May 2022 | UK£6.8b | UK£1.1b | -UK£144,620,420.00 | 33.4x | -47.1x | 6.1x |
| Wed, 06 Apr 2022 | UK£7.5b | UK£1.1b | -UK£87,549,971.00 | 42.1x | -85.4x | 6.8x |
| Fri, 04 Mar 2022 | UK£7.7b | UK£1.1b | -UK£132,291,384.00 | 32.1x | -58.1x | 7.1x |
| Sun, 30 Jan 2022 | UK£9.0b | UK£1.1b | -UK£119,749,594.00 | 37.6x | -75.2x | 8.3x |
| Tue, 28 Dec 2021 | UK£11.3b | UK£1.1b | -UK£120,882,103.00 | 55.9x | -93.9x | 10.4x |
| Thu, 25 Nov 2021 | UK£11.1b | UK£1.1b | -UK£122,862,786.00 | 62.8x | -90.3x | 10.2x |
| Sat, 23 Oct 2021 | UK£12.6b | UK£1.1b | -UK£148,383,485.00 | 72.6x | -84.7x | 11.4x |
| Mon, 20 Sep 2021 | UK£12.3b | UK£1.1b | -UK£143,247,781.00 | 53.8x | -85.8x | 11.7x |
| Wed, 18 Aug 2021 | UK£12.4b | UK£1.0b | -UK£172,541,949.91 | 29.7x | -71.8x | 12.1x |
Price to Earnings Ratio
-65x
Current Industry PE
- Investors are pessimistic on the British Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 7.2x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 6.4% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | -0.30% | |
| Healthcare | 0.38% | |
| Biotech | 1.39% | |
| Biotech | 1.39% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GNS Genus | UK£18.32 | 4.4% +UK£51.1m | -25.5% | PE36x | |
| OXB Oxford Biomedica | UK£3.26 | 3.3% +UK£10.5m | -30.0% | PS3.6x | |
| PRTC PureTech Health | UK£2.32 | 1.3% +UK£8.2m | -1.9% | PS240.5x | |
| AVCT Avacta Group | UK£0.42 | 1.7% +UK£2.5m | -61.6% | PS6.5x | |
| TRX Tissue Regenix Group | UK£0.69 | 5.3% +UK£2.5m | 35.3% | PS2.1x |